Work

Phase 1 Study of CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR) Therapy in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia (ALL)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117445

Authors: Liora M Schultz, Kara L. Davis, Christina Baggott, Christie Chaudry, Anne Cunniffe Marcy, Sharon Mavroukakis, Bita Sahaf, Katherine A Kong, Lori S Muffly, Stephen Kim, Everett H Meyer, Terry J. Fry, Haiying Qin, David B. Miklos, Crystal L. Mackall

Institutions: Stanford Medicine, Stanford University, University of Colorado Anschutz, University of Colorado Denver, National Cancer Institute, Center for Cancer Research

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2905858534

Cites:

Cited by: 52

Related to: 10